Zegerid Powder, For Suspension
NDC Package 68012-052-30
Package Information
Zegerid (omeprazole and sodium bicarbonate) powders is zEGERID for oral suspension and ZEGERID capsules are indicated in adults for the:•short-term treatment of active duodenal ulcer. This formulation utilizes a powder, for suspension delivery system. Marketed by Santarus, Inc.., this product is identified by NDC 68012-052 and is authorized under FDA application NDA021636.
Identification & Billing
- RxCUI: 616539 - omeprazole 20 MG / sodium bicarbonate 1100 MG Oral Capsule
- RxCUI: 616539 - Omeprazole 20 MG / NaHCO3 1100 MG Oral Capsule
- RxCUI: 616541 - omeprazole 40 MG / sodium bicarbonate 1100 MG Oral Capsule
- RxCUI: 616541 - Omeprazole 40 MG / NaHCO3 1100 MG Oral Capsule
- RxCUI: 646344 - Zegerid 20 MG / 1100 MG Oral Capsule, Reformulated Aug 2006
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68012 - Santarus, Inc..
- 68012-052 - Zegerid
- 68012-052-30 - 30 PACKET in 1 CARTON / 1 POWDER, FOR SUSPENSION in 1 PACKET
- 68012-052 - Zegerid
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68012-052-30 identifies a specific commercial package of 30 packet in 1 carton / 1 powder, for suspension in 1 packet of Zegerid, a human prescription drug labeled by Santarus, Inc... This powder, for suspension is formulated for oral use and contains omeprazole; sodium bicarbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Santarus, Inc.. on June 15, 2004. The current certification is valid through December 31, 2027.
How is this Santarus, Inc.. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68012005230. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.